NCT06473454 Patients With Irritable Bowel Syndrome and Physiotherapy
| NCT ID | NCT06473454 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Saglik Bilimleri University |
| Condition | Irritable Bowel Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2024-07-20 |
| Primary Completion | 2024-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2024-07-20 with a primary completion date of 2024-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The research will be planned on 72 individuals between the ages of 18-65 who were diagnosed with irritable bowel syndrome at Istanbul Medipol University Çamlıca SUAM Gastroenterology Polyclinic. Patients will be divided into 3 groups; High-intensity interval training and a disease-specific nutrition program for the first group, and a disease-specific nutrition program for the second group; Basic Body Awareness Therapy (BBAT) and a disease-specific nutrition program will be given, while the control group will be given only a disease-specific nutrition program. Evaluations will be made immediately before and after treatment. The first experimental group will be asked to walk with high-intensity interval training, which the investigators plan for 30 minutes, 4 days a week for 8 weeks. TBFT will be applied to the second experimental group every day of the week. The application will be done face to face one day a week, and the patient will be asked to do it himself on the other days, and the sessions will last approximately 30 minutes. In addition, all patients will be asked to follow the nutrition program determined by the dietician. Participants' sociodemographic information, IBS disease type and medications used will be recorded. In order to collect data for both the intervention groups and the control group immediately before and after the study; 6 Minute Walk Test (6MWT), posture analysis, muscle shortness test for large muscle groups in the lower and upper extremities, International Physical Activity Questionnaire Short Form (IPAQ-SF), Diet Compliance Questionnaire Form, Bristol Stool Scale Form, Gastrointestinal Symptom Assessment Scale (GSDS). ), Pittsburgh Sleep Quality Index (PSQI), IBS Quality of Life Scale (IBS-QOL), Morningness-Eveningness Questionnaire (SAA), Psychological Well-Being Scale (PIOS) and Body Awareness Questionnaire (VFA) will be used.
Eligibility Criteria
inclusion criterias 1\. Being between the ages of 18-65 2. Compliance with Rome IV criteria 3. Declaring that you wish to participate in the study with written consent exclusion criterias 1. Voluntary refusal to participate in the study 2. Having a psychiatric illness 3. Not having any orthopedic, neurological or cardiopulmonary disease that would constitute a contraindication for the protocols to be applied. 4. Do not pose any risk of injury while working in line with posture analysis. 5. In case the limitations in muscle shortness tests prevent the study 6. Using laxatives regularly 7. Being diagnosed with diabetes or a metabolic disease that will affect the gastrointestinal system 8. No history of Inflammatory Bowel Disease (IBD), colon cancer or colon resection 9. Using antibiotics and probiotics in the last 3 months 10. Using anticholinergic, opiate or morphine-type drugs that will affect intestinal motility 11. Getting diagnosed with celiac disease
Frequently Asked Questions
Who can join the NCT06473454 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Irritable Bowel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06473454 currently recruiting?
Yes, NCT06473454 is actively recruiting participants. Visit ClinicalTrials.gov or contact Istanbul Saglik Bilimleri University to inquire about joining.
Where is the NCT06473454 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06473454 clinical trial?
NCT06473454 is sponsored by Istanbul Saglik Bilimleri University. The trial plans to enroll 72 participants.